Cargando…
mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK
mir-101-3p has been reported to be a tumor suppressor and a promising therapeutic target in cancer. Recently, AMPK dysfunction has been highlighted in cancers, including breast cancer. The aim of this study is to investigate the biological roles of mir-101-3p and AMPK in breast cancer. Our research...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085220/ https://www.ncbi.nlm.nih.gov/pubmed/27145268 http://dx.doi.org/10.18632/oncotarget.9072 |